

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | myoblast migration (GO:0051451) | 8.10469521 |
| 2 | positive regulation of osteoblast proliferation (GO:0033690) | 6.58616415 |
| 3 | keratan sulfate catabolic process (GO:0042340) | 6.48011051 |
| 4 | biomineral tissue development (GO:0031214) | 5.88274609 |
| 5 | keratan sulfate biosynthetic process (GO:0018146) | 5.75185503 |
| 6 | muscle cell migration (GO:0014812) | 5.69605838 |
| 7 | peripheral nervous system axon ensheathment (GO:0032292) | 5.64917625 |
| 8 | myelination in peripheral nervous system (GO:0022011) | 5.64917625 |
| 9 | glomerular basement membrane development (GO:0032836) | 5.50685377 |
| 10 | cartilage condensation (GO:0001502) | 5.15501061 |
| 11 | cell aggregation (GO:0098743) | 5.15501061 |
| 12 | negative regulation of bone mineralization (GO:0030502) | 5.11129401 |
| 13 | protein heterotrimerization (GO:0070208) | 4.99976595 |
| 14 | epithelial cell-cell adhesion (GO:0090136) | 4.97715773 |
| 15 | negative regulation of biomineral tissue development (GO:0070168) | 4.92529384 |
| 16 | collagen fibril organization (GO:0030199) | 4.85331495 |
| 17 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.79084434 |
| 18 | extracellular fibril organization (GO:0043206) | 4.69070765 |
| 19 | negative regulation of stress fiber assembly (GO:0051497) | 4.61835703 |
| 20 | fibril organization (GO:0097435) | 4.47863983 |
| 21 | molting cycle (GO:0042303) | 4.40545996 |
| 22 | hair cycle (GO:0042633) | 4.40545996 |
| 23 | negative regulation of Rho protein signal transduction (GO:0035024) | 4.39943712 |
| 24 | venous blood vessel morphogenesis (GO:0048845) | 4.39581902 |
| 25 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.21152629 |
| 26 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 4.13298541 |
| 27 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 4.12523831 |
| 28 | replacement ossification (GO:0036075) | 4.10492062 |
| 29 | endochondral ossification (GO:0001958) | 4.10492062 |
| 30 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.09880495 |
| 31 | negative regulation of complement activation (GO:0045916) | 4.05397593 |
| 32 | dermatan sulfate biosynthetic process (GO:0030208) | 4.04916644 |
| 33 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 4.02858048 |
| 34 | ossification (GO:0001503) | 3.98844058 |
| 35 | protein retention in ER lumen (GO:0006621) | 3.92611253 |
| 36 | Golgi transport vesicle coating (GO:0048200) | 3.92423286 |
| 37 | COPI coating of Golgi vesicle (GO:0048205) | 3.92423286 |
| 38 | behavioral response to pain (GO:0048266) | 3.90459432 |
| 39 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.83710313 |
| 40 | dermatan sulfate metabolic process (GO:0030205) | 3.79391215 |
| 41 | bone development (GO:0060348) | 3.75513976 |
| 42 | striated muscle hypertrophy (GO:0014897) | 3.68660063 |
| 43 | somite development (GO:0061053) | 3.63340048 |
| 44 | tissue remodeling (GO:0048771) | 3.63257114 |
| 45 | urate metabolic process (GO:0046415) | 3.59943475 |
| 46 | endothelial cell morphogenesis (GO:0001886) | 3.57758136 |
| 47 | negative regulation of ossification (GO:0030279) | 3.55232835 |
| 48 | lymph vessel development (GO:0001945) | 3.52220101 |
| 49 | negative regulation of BMP signaling pathway (GO:0030514) | 3.49104213 |
| 50 | regulation of tissue remodeling (GO:0034103) | 3.48552623 |
| 51 | muscle hypertrophy (GO:0014896) | 3.47473227 |
| 52 | regulation of bone remodeling (GO:0046850) | 3.43865421 |
| 53 | cellular response to vitamin D (GO:0071305) | 3.43580255 |
| 54 | regulation of bone mineralization (GO:0030500) | 3.42556783 |
| 55 | regulation of osteoblast proliferation (GO:0033688) | 3.40749035 |
| 56 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.40161317 |
| 57 | glomerular filtration (GO:0003094) | 3.39892164 |
| 58 | limb development (GO:0060173) | 3.38949586 |
| 59 | appendage development (GO:0048736) | 3.38949586 |
| 60 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.38664590 |
| 61 | regulation of biomineral tissue development (GO:0070167) | 3.33037363 |
| 62 | positive regulation of chemokine secretion (GO:0090197) | 3.32756750 |
| 63 | drug transmembrane transport (GO:0006855) | 3.32543514 |
| 64 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.30452616 |
| 65 | regulation of alkaline phosphatase activity (GO:0010692) | 3.28388857 |
| 66 | chondrocyte development (GO:0002063) | 3.25625098 |
| 67 | striated muscle cell proliferation (GO:0014855) | 3.23221742 |
| 68 | positive regulation of focal adhesion assembly (GO:0051894) | 3.22550096 |
| 69 | positive regulation of cell junction assembly (GO:1901890) | 3.22550096 |
| 70 | type B pancreatic cell proliferation (GO:0044342) | 3.21325152 |
| 71 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.20638407 |
| 72 | decidualization (GO:0046697) | 3.19938848 |
| 73 | cartilage development (GO:0051216) | 3.19370509 |
| 74 | collagen metabolic process (GO:0032963) | 3.19345909 |
| 75 | COPII vesicle coating (GO:0048208) | 3.16895825 |
| 76 | positive regulation of p38MAPK cascade (GO:1900745) | 3.16218261 |
| 77 | negative regulation of protein activation cascade (GO:2000258) | 3.16144283 |
| 78 | glucuronate metabolic process (GO:0019585) | 3.15476432 |
| 79 | uronic acid metabolic process (GO:0006063) | 3.15476432 |
| 80 | positive regulation of neutrophil migration (GO:1902624) | 3.14068064 |
| 81 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.14068064 |
| 82 | collagen catabolic process (GO:0030574) | 3.13075859 |
| 83 | thrombin receptor signaling pathway (GO:0070493) | 3.12324318 |
| 84 | import into cell (GO:0098657) | 3.10774485 |
| 85 | barbed-end actin filament capping (GO:0051016) | 3.08506591 |
| 86 | positive regulation of adherens junction organization (GO:1903393) | 3.08277976 |
| 87 | cellular glucuronidation (GO:0052695) | 3.08081689 |
| 88 | interkinetic nuclear migration (GO:0022027) | 3.07880274 |
| 89 | regulation of protein polyubiquitination (GO:1902914) | 3.07267774 |
| 90 | positive regulation of receptor internalization (GO:0002092) | 3.06902483 |
| 91 | plasma membrane repair (GO:0001778) | 3.04689416 |
| 92 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.03948080 |
| 93 | lymphangiogenesis (GO:0001946) | 3.03617276 |
| 94 | regulation of extracellular matrix disassembly (GO:0010715) | 3.02008419 |
| 95 | renal filtration (GO:0097205) | 3.01531549 |
| 96 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.01227478 |
| 97 | radial glial cell differentiation (GO:0060019) | 2.99761035 |
| 98 | sulfur compound catabolic process (GO:0044273) | 2.99713242 |
| 99 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.99320034 |
| 100 | extracellular matrix assembly (GO:0085029) | 2.99034373 |
| 101 | skeletal system development (GO:0001501) | 2.96394201 |
| 102 | fucose metabolic process (GO:0006004) | 2.95912747 |
| 103 | bone mineralization (GO:0030282) | 2.94119205 |
| 104 | cardiac muscle cell proliferation (GO:0060038) | 2.92363516 |
| 105 | glycoside metabolic process (GO:0016137) | 2.90875063 |
| 106 | phosphate ion transmembrane transport (GO:0035435) | 2.90336344 |
| 107 | positive regulation of cell-substrate adhesion (GO:0010811) | 2.89948085 |
| 108 | multicellular organismal catabolic process (GO:0044243) | 2.89615011 |
| 109 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.89300233 |
| 110 | peptide catabolic process (GO:0043171) | 2.88625093 |
| 111 | multicellular organismal metabolic process (GO:0044236) | 2.87634033 |
| 112 | vasculature development (GO:0001944) | 2.87568653 |
| 113 | hair follicle morphogenesis (GO:0031069) | 2.86653936 |
| 114 | cellular response to vitamin (GO:0071295) | 2.86606554 |
| 115 | signal peptide processing (GO:0006465) | 2.83773544 |
| 116 | striated muscle adaptation (GO:0014888) | 2.80927324 |
| 117 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.80342891 |
| 118 | organic cation transport (GO:0015695) | 2.80207481 |
| 119 | phagocytosis, recognition (GO:0006910) | 2.79196989 |
| 120 | opsonization (GO:0008228) | 2.78734959 |
| 121 | glycosaminoglycan catabolic process (GO:0006027) | 2.76261545 |
| 122 | neuronal ion channel clustering (GO:0045161) | 2.74615646 |
| 123 | pericardium development (GO:0060039) | 2.74143276 |
| 124 | establishment of tissue polarity (GO:0007164) | 2.73672278 |
| 125 | establishment of planar polarity (GO:0001736) | 2.73672278 |
| 126 | wound healing, spreading of epidermal cells (GO:0035313) | 2.73050061 |
| 127 | chondroitin sulfate catabolic process (GO:0030207) | 2.72913350 |
| 128 | cochlea morphogenesis (GO:0090103) | 2.72338474 |
| 129 | drug transport (GO:0015893) | 2.71148090 |
| 130 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.69911316 |
| 131 | camera-type eye morphogenesis (GO:0048593) | 2.69690613 |
| 132 | growth hormone receptor signaling pathway (GO:0060396) | 2.69216833 |
| 133 | regulation of p38MAPK cascade (GO:1900744) | 2.68400832 |
| 134 | hematopoietic stem cell proliferation (GO:0071425) | 2.66296321 |
| 135 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.65128523 |
| 136 | tooth mineralization (GO:0034505) | 2.64411238 |
| 137 | iron ion import (GO:0097286) | 2.64141661 |
| 138 | bone resorption (GO:0045453) | 2.64027023 |
| 139 | negative regulation of protein autophosphorylation (GO:0031953) | 2.62711220 |
| 140 | exocrine pancreas development (GO:0031017) | 2.62704736 |
| 141 | aminoglycan catabolic process (GO:0006026) | 2.62505681 |
| 142 | wound healing, spreading of cells (GO:0044319) | 2.61882571 |
| 143 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.61289146 |
| 144 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.60793880 |
| 145 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.60104629 |
| 146 | extracellular matrix disassembly (GO:0022617) | 2.59934969 |
| 147 | tricarboxylic acid metabolic process (GO:0072350) | 2.57713880 |
| 148 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.55956288 |
| 149 | extracellular matrix organization (GO:0030198) | 2.55461946 |
| 150 | extracellular structure organization (GO:0043062) | 2.54121964 |
| 151 | chondrocyte proliferation (GO:0035988) | 2.52991612 |
| 152 | regulation of interleukin-8 secretion (GO:2000482) | 2.50238915 |
| 153 | skeletal muscle adaptation (GO:0043501) | 2.50109075 |
| 154 | non-canonical Wnt signaling pathway (GO:0035567) | 2.49037693 |
| 155 | negative regulation of humoral immune response (GO:0002921) | 2.47711569 |
| 156 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.46162385 |
| 157 | bone trabecula formation (GO:0060346) | 2.46096978 |
| 158 | response to copper ion (GO:0046688) | 2.45135166 |
| 159 | type B pancreatic cell development (GO:0003323) | 2.43296531 |
| 160 | trivalent inorganic anion homeostasis (GO:0072506) | 2.43184011 |
| 161 | phosphate ion homeostasis (GO:0055062) | 2.43184011 |
| 162 | regulation of skeletal muscle contraction (GO:0014819) | 2.43113650 |
| 163 | keratan sulfate metabolic process (GO:0042339) | 2.40621033 |
| 164 | endodermal cell differentiation (GO:0035987) | 2.40425121 |
| 165 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.39671338 |
| 166 | removal of superoxide radicals (GO:0019430) | 2.38943703 |
| 167 | cellular response to superoxide (GO:0071451) | 2.38943703 |
| 168 | cellular response to oxygen radical (GO:0071450) | 2.38943703 |
| 169 | hemidesmosome assembly (GO:0031581) | 2.38516653 |
| 170 | ventricular septum development (GO:0003281) | 2.36798742 |
| 171 | membrane raft organization (GO:0031579) | 2.36519858 |
| 172 | phosphate ion transport (GO:0006817) | 2.34512883 |
| 173 | vitamin A metabolic process (GO:0006776) | 2.34487073 |
| 174 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.33286728 |
| 175 | gland morphogenesis (GO:0022612) | 2.32581855 |
| 176 | nucleotide-sugar metabolic process (GO:0009225) | 2.31566208 |
| 177 | negative regulation of norepinephrine secretion (GO:0010700) | 2.31515723 |
| 178 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.31236190 |
| 179 | growth hormone secretion (GO:0030252) | 2.30740443 |
| 180 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.30041484 |
| 181 | response to parathyroid hormone (GO:0071107) | 11.0155492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.36841417 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.68740990 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.00992818 |
| 4 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.35893236 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.12653324 |
| 6 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.54718581 |
| 7 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.47368735 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.32092665 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.29084852 |
| 10 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.26979335 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.26903987 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.13506646 |
| 13 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.99982117 |
| 14 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.99982117 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.99864722 |
| 16 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.95589681 |
| 17 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.91804646 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.88353832 |
| 19 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.86912708 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.86369447 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.86248517 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.85939128 |
| 23 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.85754421 |
| 24 | TP53_16413492_ChIP-PET_HCT116_Human | 1.72311446 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69729746 |
| 26 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.68727642 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.67355685 |
| 28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62654763 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.62381263 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.57583199 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.55107253 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.51745861 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.51563047 |
| 34 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.51394221 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.49446201 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.48458164 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.46380235 |
| 38 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.45755215 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44229599 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41299053 |
| 41 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33755578 |
| 42 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31020824 |
| 43 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.29970204 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29921736 |
| 45 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.29868192 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29533060 |
| 47 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27994498 |
| 48 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.27370529 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27141765 |
| 50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26991711 |
| 51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25682227 |
| 52 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25671132 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.25513274 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24606920 |
| 55 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24047552 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23715590 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23544091 |
| 58 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.22863660 |
| 59 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.22084407 |
| 60 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21932241 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20821814 |
| 62 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20134965 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18958139 |
| 64 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.17595609 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17225110 |
| 66 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.16957854 |
| 67 | RXR_22108803_ChIP-Seq_LS180_Human | 1.16475135 |
| 68 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16134029 |
| 69 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15519645 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15022698 |
| 71 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.14032471 |
| 72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13984071 |
| 73 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13259773 |
| 74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13259773 |
| 75 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13089175 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12897331 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11938503 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.11603572 |
| 79 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11572775 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10697308 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10230731 |
| 82 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09827330 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09461734 |
| 84 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09190159 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08869353 |
| 86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08869353 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08690087 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07092936 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04909063 |
| 90 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.04613056 |
| 91 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04371975 |
| 92 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04145941 |
| 93 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.03206870 |
| 94 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02227022 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02172185 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01407776 |
| 97 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.00508076 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00068954 |
| 99 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.98910868 |
| 100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97233980 |
| 101 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94697149 |
| 102 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.94486333 |
| 103 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94474656 |
| 104 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.92815877 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91911711 |
| 106 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91521948 |
| 107 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.91520932 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91472184 |
| 109 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91226101 |
| 110 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90043356 |
| 111 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90040400 |
| 112 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89973118 |
| 113 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89926587 |
| 114 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89424575 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.89291737 |
| 116 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.89250477 |
| 117 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.89166144 |
| 118 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87438510 |
| 119 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.84921747 |
| 120 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84173417 |
| 121 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.83901238 |
| 122 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82966873 |
| 123 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.82746665 |
| 124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82672900 |
| 125 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.82434467 |
| 126 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.81502178 |
| 127 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81430771 |
| 128 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81084418 |
| 129 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80190918 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80091739 |
| 131 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.79866353 |
| 132 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79852353 |
| 133 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78125638 |
| 134 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78125638 |
| 135 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.78026505 |
| 136 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.77546552 |
| 137 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.77140204 |
| 138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76993720 |
| 139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76585400 |
| 140 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.76166280 |
| 141 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.75926510 |
| 142 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.74899593 |
| 143 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.74564835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 7.64331906 |
| 2 | MP0005503_abnormal_tendon_morphology | 6.68673452 |
| 3 | MP0001958_emphysema | 5.06626608 |
| 4 | MP0005275_abnormal_skin_tensile | 5.03350405 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.53635044 |
| 6 | MP0005377_hearing/vestibular/ear_phenot | 3.24884507 |
| 7 | MP0003878_abnormal_ear_physiology | 3.24884507 |
| 8 | MP0009384_cardiac_valve_regurgitation | 3.18642090 |
| 9 | MP0010368_abnormal_lymphatic_system | 3.03398352 |
| 10 | MP0003279_aneurysm | 2.81345925 |
| 11 | MP0001661_extended_life_span | 2.81194049 |
| 12 | MP0003283_abnormal_digestive_organ | 2.36537028 |
| 13 | MP0002060_abnormal_skin_morphology | 2.22922204 |
| 14 | MP0002933_joint_inflammation | 2.22180259 |
| 15 | MP0003724_increased_susceptibility_to | 2.18302094 |
| 16 | MP0006054_spinal_hemorrhage | 2.14800931 |
| 17 | MP0002108_abnormal_muscle_morphology | 2.09099222 |
| 18 | MP0000751_myopathy | 2.01911964 |
| 19 | MP0005257_abnormal_intraocular_pressure | 2.00865511 |
| 20 | MP0003195_calcinosis | 1.98553202 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 1.98073819 |
| 22 | MP0005083_abnormal_biliary_tract | 1.96191565 |
| 23 | MP0005508_abnormal_skeleton_morphology | 1.80191502 |
| 24 | MP0002109_abnormal_limb_morphology | 1.78277276 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.72035321 |
| 26 | MP0001879_abnormal_lymphatic_vessel | 1.70846052 |
| 27 | MP0003252_abnormal_bile_duct | 1.69859273 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.69110430 |
| 29 | MP0002295_abnormal_pulmonary_circulatio | 1.68178901 |
| 30 | MP0002102_abnormal_ear_morphology | 1.67678651 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.56103666 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.55373864 |
| 33 | MP0010386_abnormal_urinary_bladder | 1.48897900 |
| 34 | MP0005220_abnormal_exocrine_pancreas | 1.48677156 |
| 35 | MP0004272_abnormal_basement_membrane | 1.42699957 |
| 36 | MP0004043_abnormal_pH_regulation | 1.39824567 |
| 37 | MP0005171_absent_coat_pigmentation | 1.38695050 |
| 38 | MP0005390_skeleton_phenotype | 1.35665817 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.32619141 |
| 40 | MP0000749_muscle_degeneration | 1.32327867 |
| 41 | MP0005248_abnormal_Harderian_gland | 1.30153815 |
| 42 | MP0002896_abnormal_bone_mineralization | 1.28594174 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.27771326 |
| 44 | MP0002928_abnormal_bile_duct | 1.27710008 |
| 45 | MP0001765_abnormal_ion_homeostasis | 1.26672673 |
| 46 | MP0003646_muscle_fatigue | 1.25483962 |
| 47 | MP0000579_abnormal_nail_morphology | 1.21792766 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.21736059 |
| 49 | MP0004885_abnormal_endolymph | 1.20911985 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.19498039 |
| 51 | MP0001542_abnormal_bone_strength | 1.15763946 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.15596711 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.13603992 |
| 54 | MP0003795_abnormal_bone_structure | 1.13195039 |
| 55 | MP0000343_altered_response_to | 1.11202519 |
| 56 | MP0001243_abnormal_dermal_layer | 1.08766925 |
| 57 | MP0009250_abnormal_appendicular_skeleto | 1.06894662 |
| 58 | MP0005332_abnormal_amino_acid | 1.06608879 |
| 59 | MP0002168_other_aberrant_phenotype | 1.04263825 |
| 60 | MP0004233_abnormal_muscle_weight | 1.03406376 |
| 61 | MP0000163_abnormal_cartilage_morphology | 1.01726829 |
| 62 | MP0000538_abnormal_urinary_bladder | 1.01303694 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.00722285 |
| 64 | MP0002115_abnormal_skeleton_extremities | 1.00570390 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 0.99627239 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 0.94512530 |
| 67 | MP0003935_abnormal_craniofacial_develop | 0.93538780 |
| 68 | MP0005388_respiratory_system_phenotype | 0.92892114 |
| 69 | MP0002133_abnormal_respiratory_system | 0.92892114 |
| 70 | MP0000767_abnormal_smooth_muscle | 0.91790489 |
| 71 | MP0001944_abnormal_pancreas_morphology | 0.90665979 |
| 72 | MP0002113_abnormal_skeleton_development | 0.90197302 |
| 73 | MP0006082_CNS_inflammation | 0.89391951 |
| 74 | MP0000647_abnormal_sebaceous_gland | 0.88667525 |
| 75 | MP0005369_muscle_phenotype | 0.84998330 |
| 76 | MP0000432_abnormal_head_morphology | 0.83604120 |
| 77 | MP0004484_altered_response_of | 0.83589522 |
| 78 | MP0001177_atelectasis | 0.83283606 |
| 79 | MP0005330_cardiomyopathy | 0.81189932 |
| 80 | MP0003385_abnormal_body_wall | 0.80568076 |
| 81 | MP0003011_delayed_dark_adaptation | 0.79850789 |
| 82 | MP0005253_abnormal_eye_physiology | 0.79847547 |
| 83 | MP0005023_abnormal_wound_healing | 0.79444871 |
| 84 | MP0001756_abnormal_urination | 0.78882301 |
| 85 | MP0005670_abnormal_white_adipose | 0.78558952 |
| 86 | MP0000759_abnormal_skeletal_muscle | 0.77651815 |
| 87 | MP0005595_abnormal_vascular_smooth | 0.76550516 |
| 88 | MP0010030_abnormal_orbit_morphology | 0.74261272 |
| 89 | MP0005365_abnormal_bile_salt | 0.73446008 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.73266534 |
| 91 | MP0005620_abnormal_muscle_contractility | 0.72260180 |
| 92 | MP0009115_abnormal_fat_cell | 0.71719217 |
| 93 | MP0000747_muscle_weakness | 0.71705558 |
| 94 | MP0002116_abnormal_craniofacial_bone | 0.71144518 |
| 95 | MP0002932_abnormal_joint_morphology | 0.71016262 |
| 96 | MP0005165_increased_susceptibility_to | 0.70314786 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.70113245 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.69289898 |
| 99 | MP0003045_fibrosis | 0.68734132 |
| 100 | MP0005166_decreased_susceptibility_to | 0.65155059 |
| 101 | MP0005360_urolithiasis | 0.64905465 |
| 102 | MP0003448_altered_tumor_morphology | 0.64775360 |
| 103 | MP0000678_abnormal_parathyroid_gland | 0.64466952 |
| 104 | MP0002098_abnormal_vibrissa_morphology | 0.63297640 |
| 105 | MP0005551_abnormal_eye_electrophysiolog | 0.63177488 |
| 106 | MP0003186_abnormal_redox_activity | 0.62732539 |
| 107 | MP0003950_abnormal_plasma_membrane | 0.61675338 |
| 108 | MP0003091_abnormal_cell_migration | 0.61429960 |
| 109 | MP0003828_pulmonary_edema | 0.60041545 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.58915011 |
| 111 | MP0002106_abnormal_muscle_physiology | 0.58458289 |
| 112 | MP0002139_abnormal_hepatobiliary_system | 0.57650805 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.56912245 |
| 114 | MP0004036_abnormal_muscle_relaxation | 0.56772192 |
| 115 | MP0001502_abnormal_circadian_rhythm | 0.56507631 |
| 116 | MP0005197_abnormal_uvea_morphology | 0.56422913 |
| 117 | MP0000681_abnormal_thyroid_gland | 0.55601288 |
| 118 | MP0002233_abnormal_nose_morphology | 0.52593272 |
| 119 | MP0001986_abnormal_taste_sensitivity | 0.52189630 |
| 120 | MP0006072_abnormal_retinal_apoptosis | 0.52157192 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.51575390 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.50737756 |
| 123 | MP0000733_abnormal_muscle_development | 0.50661773 |
| 124 | MP0002254_reproductive_system_inflammat | 0.50543262 |
| 125 | MP0002269_muscular_atrophy | 0.50498784 |
| 126 | MP0002972_abnormal_cardiac_muscle | 0.50390613 |
| 127 | MP0005164_abnormal_response_to | 0.49778548 |
| 128 | MP0003172_abnormal_lysosome_physiology | 0.48290748 |
| 129 | MP0003959_abnormal_lean_body | 0.48274355 |
| 130 | MP0001324_abnormal_eye_pigmentation | 0.47995080 |
| 131 | MP0004087_abnormal_muscle_fiber | 0.47740339 |
| 132 | MP0001664_abnormal_digestion | 0.47624145 |
| 133 | MP0002114_abnormal_axial_skeleton | 0.46901661 |
| 134 | MP0004381_abnormal_hair_follicle | 0.45862723 |
| 135 | MP0003941_abnormal_skin_development | 0.45420546 |
| 136 | MP0004130_abnormal_muscle_cell | 0.45402929 |
| 137 | MP0004084_abnormal_cardiac_muscle | 0.45258176 |
| 138 | MP0002090_abnormal_vision | 0.44813920 |
| 139 | MP0005187_abnormal_penis_morphology | 0.44579971 |
| 140 | MP0002009_preneoplasia | 0.43560611 |
| 141 | MP0005193_abnormal_anterior_eye | 0.43413008 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.42972353 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.42379471 |
| 144 | MP0000026_abnormal_inner_ear | 0.41899320 |
| 145 | MP0005623_abnormal_meninges_morphology | 0.41775145 |
| 146 | MP0005375_adipose_tissue_phenotype | 0.40225791 |
| 147 | MP0002128_abnormal_blood_circulation | 0.39189028 |
| 148 | MP0002166_altered_tumor_susceptibility | 0.39170751 |
| 149 | MP0005423_abnormal_somatic_nervous | 0.38778061 |
| 150 | MP0002638_abnormal_pupillary_reflex | 0.37760357 |
| 151 | MP0005084_abnormal_gallbladder_morpholo | 0.36148076 |
| 152 | MP0000428_abnormal_craniofacial_morphol | 0.35676904 |
| 153 | MP0005395_other_phenotype | 0.34396571 |
| 154 | MP0003868_abnormal_feces_composition | 0.32791365 |
| 155 | MP0003718_maternal_effect | 0.32513110 |
| 156 | MP0005391_vision/eye_phenotype | 0.32373560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypophosphatemic rickets (HP:0004912) | 9.03859459 |
| 2 | Increased density of long bones (HP:0006392) | 7.37883500 |
| 3 | Abnormality of the vertebral endplates (HP:0005106) | 7.10625541 |
| 4 | Metaphyseal dysplasia (HP:0100255) | 6.73237522 |
| 5 | Premature rupture of membranes (HP:0001788) | 6.24624518 |
| 6 | Protrusio acetabuli (HP:0003179) | 6.21339133 |
| 7 | Spinal cord compression (HP:0002176) | 5.98773402 |
| 8 | Mild short stature (HP:0003502) | 5.72942637 |
| 9 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 5.68891039 |
| 10 | Irregular vertebral endplates (HP:0003301) | 5.44390147 |
| 11 | Facial diplegia (HP:0001349) | 5.39209193 |
| 12 | Metaphyseal cupping (HP:0003021) | 4.90198521 |
| 13 | Small epiphyses (HP:0010585) | 4.87775367 |
| 14 | Vascular tortuosity (HP:0004948) | 4.69330159 |
| 15 | Craniofacial hyperostosis (HP:0004493) | 4.61196237 |
| 16 | Arterial tortuosity (HP:0005116) | 4.56495691 |
| 17 | Enlarged epiphyses (HP:0010580) | 4.42683045 |
| 18 | Wrist flexion contracture (HP:0001239) | 4.36146800 |
| 19 | Aortic aneurysm (HP:0004942) | 4.26577794 |
| 20 | Soft skin (HP:0000977) | 4.20527810 |
| 21 | Tibial bowing (HP:0002982) | 4.17347829 |
| 22 | Cranial hyperostosis (HP:0004437) | 3.99851548 |
| 23 | Rickets (HP:0002748) | 3.96904619 |
| 24 | Vertebral compression fractures (HP:0002953) | 3.77003449 |
| 25 | Choanal stenosis (HP:0000452) | 3.72220458 |
| 26 | Femoral bowing (HP:0002980) | 3.65758118 |
| 27 | Osteomalacia (HP:0002749) | 3.60452327 |
| 28 | Carpal bone hypoplasia (HP:0001498) | 3.57871716 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 3.57835995 |
| 30 | Sudden death (HP:0001699) | 3.46506511 |
| 31 | Genu varum (HP:0002970) | 3.43562241 |
| 32 | Joint stiffness (HP:0001387) | 3.38239920 |
| 33 | Aortic dissection (HP:0002647) | 3.38089487 |
| 34 | Fragile skin (HP:0001030) | 3.36324896 |
| 35 | Beaking of vertebral bodies (HP:0004568) | 3.35662571 |
| 36 | Esophageal neoplasm (HP:0100751) | 3.28392877 |
| 37 | Neoplasm of head and neck (HP:0012288) | 3.28392877 |
| 38 | Subacute progressive viral hepatitis (HP:0006572) | 3.23314475 |
| 39 | Hypophosphatemia (HP:0002148) | 3.19296169 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.18597794 |
| 41 | Metaphyseal irregularity (HP:0003025) | 3.16450472 |
| 42 | Bladder diverticulum (HP:0000015) | 3.16302756 |
| 43 | Generalized aminoaciduria (HP:0002909) | 3.15936297 |
| 44 | Type 1 muscle fiber predominance (HP:0003803) | 3.12994449 |
| 45 | Dysostosis multiplex (HP:0000943) | 3.08830428 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.05134562 |
| 47 | Mucopolysacchariduria (HP:0008155) | 3.05134562 |
| 48 | Spondylolisthesis (HP:0003302) | 2.98388327 |
| 49 | Hypomagnesemia (HP:0002917) | 2.98326964 |
| 50 | Ulnar deviation of the wrist (HP:0003049) | 2.97949201 |
| 51 | Atrophic scars (HP:0001075) | 2.93217842 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.92555864 |
| 53 | Broad metatarsal (HP:0001783) | 2.91735584 |
| 54 | Tetany (HP:0001281) | 2.90577244 |
| 55 | Thin bony cortex (HP:0002753) | 2.83940039 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.79341212 |
| 57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.79341212 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.79341212 |
| 59 | Osteoarthritis (HP:0002758) | 2.79323647 |
| 60 | Delayed epiphyseal ossification (HP:0002663) | 2.77984210 |
| 61 | Overgrowth (HP:0001548) | 2.73088687 |
| 62 | Cervical subluxation (HP:0003308) | 2.71711897 |
| 63 | Spinal rigidity (HP:0003306) | 2.69900515 |
| 64 | Absent frontal sinuses (HP:0002688) | 2.69655905 |
| 65 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.69331039 |
| 66 | Increased connective tissue (HP:0009025) | 2.67965305 |
| 67 | Symptomatic seizures (HP:0011145) | 2.67779168 |
| 68 | Cerebral aneurysm (HP:0004944) | 2.67199697 |
| 69 | Dilatation of the ascending aorta (HP:0005111) | 2.65759071 |
| 70 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.64013336 |
| 71 | Constricted visual fields (HP:0001133) | 2.62624022 |
| 72 | Glomerulonephritis (HP:0000099) | 2.57667824 |
| 73 | Wormian bones (HP:0002645) | 2.51863212 |
| 74 | Gout (HP:0001997) | 2.49637607 |
| 75 | Blue sclerae (HP:0000592) | 2.49074492 |
| 76 | Cardiovascular calcification (HP:0011915) | 2.48921352 |
| 77 | Abnormality of femoral epiphyses (HP:0006499) | 2.47668530 |
| 78 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.47668530 |
| 79 | Coxa vara (HP:0002812) | 2.47301438 |
| 80 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.46135922 |
| 81 | Abnormality of magnesium homeostasis (HP:0004921) | 2.45229588 |
| 82 | Hypokalemia (HP:0002900) | 2.42492024 |
| 83 | Ankle contracture (HP:0006466) | 2.41458178 |
| 84 | Ovoid vertebral bodies (HP:0003300) | 2.40524221 |
| 85 | Abnormality of the femoral head (HP:0003368) | 2.40180381 |
| 86 | Redundant skin (HP:0001582) | 2.38713290 |
| 87 | Exercise-induced muscle cramps (HP:0003710) | 2.38034172 |
| 88 | Arthropathy (HP:0003040) | 2.36585459 |
| 89 | Abnormality of Sharpey fibers (HP:0100685) | 2.29841422 |
| 90 | Hypoglycemic seizures (HP:0002173) | 2.27466262 |
| 91 | Broad ribs (HP:0000885) | 2.23652155 |
| 92 | Biconcave vertebral bodies (HP:0004586) | 2.21697069 |
| 93 | Asymmetric septal hypertrophy (HP:0001670) | 2.20862114 |
| 94 | Glucose intolerance (HP:0000833) | 2.20574127 |
| 95 | Elevated alkaline phosphatase (HP:0003155) | 2.19909194 |
| 96 | Abnormality of purine metabolism (HP:0004352) | 2.16762995 |
| 97 | Joint laxity (HP:0001388) | 2.13587744 |
| 98 | Abnormal delivery (HP:0001787) | 2.12503878 |
| 99 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11973706 |
| 100 | Osteolytic defects of the hand bones (HP:0009699) | 2.11973706 |
| 101 | Short middle phalanx of finger (HP:0005819) | 2.11575504 |
| 102 | Abnormality of the frontal sinuses (HP:0002687) | 2.11362518 |
| 103 | Round ear (HP:0100830) | 2.11043167 |
| 104 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.10963155 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 2.10665770 |
| 106 | Hypoglycemic coma (HP:0001325) | 2.09212049 |
| 107 | Abnormality of chloride homeostasis (HP:0011422) | 2.08089886 |
| 108 | Persistence of primary teeth (HP:0006335) | 2.06237099 |
| 109 | Limited hip movement (HP:0008800) | 2.04073584 |
| 110 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.02283292 |
| 111 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.02088963 |
| 112 | Aneurysm (HP:0002617) | 2.01763835 |
| 113 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00012489 |
| 114 | Papilledema (HP:0001085) | 13.1827683 |
| 115 | Mitral stenosis (HP:0001718) | 1.99967641 |
| 116 | Limited elbow extension (HP:0001377) | 1.99639372 |
| 117 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 1.97445847 |
| 118 | Hyperextensible skin (HP:0000974) | 1.97362331 |
| 119 | Flat cornea (HP:0007720) | 1.96980774 |
| 120 | Abnormality of dentin (HP:0010299) | 1.96438513 |
| 121 | Follicular hyperkeratosis (HP:0007502) | 1.96155086 |
| 122 | Striae distensae (HP:0001065) | 1.96011090 |
| 123 | Hyperactive renin-angiotensin system (HP:0000841) | 1.95833504 |
| 124 | Abnormality of the acetabulum (HP:0003170) | 1.95817592 |
| 125 | Widely patent fontanelles and sutures (HP:0004492) | 1.94626899 |
| 126 | Hypoplasia of the odontoid process (HP:0003311) | 1.93808322 |
| 127 | Mixed hearing impairment (HP:0000410) | 1.93522848 |
| 128 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93133338 |
| 129 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90210591 |
| 130 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90021644 |
| 131 | Spinal cord lesions (HP:0100561) | 1.89808161 |
| 132 | Syringomyelia (HP:0003396) | 1.89808161 |
| 133 | Muscle fiber splitting (HP:0003555) | 1.87787915 |
| 134 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86293339 |
| 135 | Flared iliac wings (HP:0002869) | 1.85024726 |
| 136 | Corneal dystrophy (HP:0001131) | 1.84547693 |
| 137 | Metabolic alkalosis (HP:0200114) | 1.84313318 |
| 138 | Abnormal cartilage morphology (HP:0002763) | 1.83726862 |
| 139 | Exercise-induced myalgia (HP:0003738) | 1.83411641 |
| 140 | Abnormality of the odontoid process (HP:0003310) | 1.83183481 |
| 141 | Irregular epiphyses (HP:0010582) | 1.82924490 |
| 142 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82902656 |
| 143 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.82746436 |
| 144 | Muscle fiber inclusion bodies (HP:0100299) | 1.82355924 |
| 145 | Abnormality of the middle phalanges of the hand (HP:0009833) | 1.81822046 |
| 146 | Hypoplasia of the iris (HP:0007676) | 1.81631181 |
| 147 | Epiphyseal dysplasia (HP:0002656) | 1.80564334 |
| 148 | Progressive visual loss (HP:0000529) | 1.80491079 |
| 149 | Congenital stationary night blindness (HP:0007642) | 1.78096374 |
| 150 | Hypokalemic alkalosis (HP:0001949) | 1.77939387 |
| 151 | Emphysema (HP:0002097) | 1.76351423 |
| 152 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.75956605 |
| 153 | Polyuria (HP:0000103) | 1.75810722 |
| 154 | Abnormal cortical bone morphology (HP:0003103) | 1.74950115 |
| 155 | Waddling gait (HP:0002515) | 1.73247402 |
| 156 | Hepatocellular carcinoma (HP:0001402) | 1.72838280 |
| 157 | Abnormality of potassium homeostasis (HP:0011042) | 1.72632027 |
| 158 | Protuberant abdomen (HP:0001538) | 1.71486837 |
| 159 | Complement deficiency (HP:0004431) | 1.71285869 |
| 160 | Pulmonary artery stenosis (HP:0004415) | 1.71251236 |
| 161 | Myopathic facies (HP:0002058) | 1.70957714 |
| 162 | Nephritis (HP:0000123) | 1.70396084 |
| 163 | Genu recurvatum (HP:0002816) | 1.63198547 |
| 164 | Spinal canal stenosis (HP:0003416) | 1.62539917 |
| 165 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.59298917 |
| 166 | Short distal phalanx of finger (HP:0009882) | 1.47314573 |
| 167 | Abnormality of complement system (HP:0005339) | 1.41647486 |
| 168 | Broad phalanx (HP:0006009) | 1.39116227 |
| 169 | Vascular calcification (HP:0004934) | 1.36618157 |
| 170 | Short femoral neck (HP:0100864) | 1.35638469 |
| 171 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.35193231 |
| 172 | Broad long bones (HP:0005622) | 1.30506989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK38L | 6.96191850 |
| 2 | STK24 | 6.30981467 |
| 3 | ERN1 | 3.36583425 |
| 4 | TGFBR2 | 3.10619366 |
| 5 | INSRR | 2.97003626 |
| 6 | GRK1 | 2.87541231 |
| 7 | PASK | 2.83335343 |
| 8 | MST1R | 2.34278324 |
| 9 | MAP3K3 | 2.16083307 |
| 10 | SGK2 | 2.14208043 |
| 11 | WNK4 | 1.90058640 |
| 12 | OBSCN | 1.84418883 |
| 13 | TTN | 1.84049686 |
| 14 | MET | 1.78018999 |
| 15 | STK3 | 1.76863046 |
| 16 | FLT3 | 1.71632893 |
| 17 | BCKDK | 1.69131639 |
| 18 | PDGFRA | 1.60915546 |
| 19 | SGK223 | 1.51914210 |
| 20 | SGK494 | 1.51914210 |
| 21 | SGK3 | 1.50819126 |
| 22 | MAP3K6 | 1.43087451 |
| 23 | DDR2 | 1.43012688 |
| 24 | FER | 1.41502864 |
| 25 | AKT3 | 1.40413443 |
| 26 | MAP3K14 | 1.38110429 |
| 27 | EEF2K | 1.36415629 |
| 28 | PIK3CG | 1.35462576 |
| 29 | PRKAA2 | 1.34620510 |
| 30 | NTRK2 | 1.33225776 |
| 31 | MOS | 1.32151392 |
| 32 | TRPM7 | 1.29292947 |
| 33 | MAPK15 | 1.27001382 |
| 34 | EPHB1 | 1.26846583 |
| 35 | CAMK1G | 1.22513485 |
| 36 | NTRK1 | 1.19773359 |
| 37 | EPHA3 | 1.17629525 |
| 38 | PTK2 | 1.17050021 |
| 39 | TYK2 | 1.15120606 |
| 40 | TAOK3 | 1.14918822 |
| 41 | FGFR4 | 1.13762974 |
| 42 | BLK | 1.08897264 |
| 43 | TEC | 1.05725659 |
| 44 | JAK3 | 1.05353961 |
| 45 | MYLK | 1.04408774 |
| 46 | RET | 1.04396794 |
| 47 | MELK | 1.03441570 |
| 48 | BMX | 1.03351880 |
| 49 | TBK1 | 0.99083463 |
| 50 | IRAK3 | 0.98824853 |
| 51 | CCNB1 | 0.97599111 |
| 52 | CDK8 | 0.97165637 |
| 53 | JAK1 | 0.94522185 |
| 54 | PAK3 | 0.93350755 |
| 55 | WNK1 | 0.92585497 |
| 56 | MAPKAPK5 | 0.91329822 |
| 57 | DYRK1B | 0.90984817 |
| 58 | HIPK2 | 0.90235787 |
| 59 | IRAK1 | 0.90043223 |
| 60 | FGFR3 | 0.89970896 |
| 61 | WNK3 | 0.89527740 |
| 62 | LATS2 | 0.88526120 |
| 63 | PTK6 | 0.86999169 |
| 64 | ERBB3 | 0.86367666 |
| 65 | PIM2 | 0.86103447 |
| 66 | PDK2 | 0.82120757 |
| 67 | TNIK | 0.81172693 |
| 68 | MARK2 | 0.77003811 |
| 69 | MAP3K7 | 0.76513325 |
| 70 | PRKCH | 0.76219239 |
| 71 | PNCK | 0.76117022 |
| 72 | FRK | 0.71359126 |
| 73 | NLK | 0.67595409 |
| 74 | IKBKB | 0.66566090 |
| 75 | CAMK1D | 0.64796404 |
| 76 | PIK3CA | 0.64256706 |
| 77 | MAPK4 | 0.61479204 |
| 78 | TRIB3 | 0.59514469 |
| 79 | GSK3A | 0.58949420 |
| 80 | ADRBK1 | 0.58846731 |
| 81 | OXSR1 | 0.58296662 |
| 82 | ABL2 | 0.58023177 |
| 83 | PINK1 | 0.57815942 |
| 84 | NEK9 | 0.57418847 |
| 85 | RIPK1 | 0.55358193 |
| 86 | MAP2K2 | 0.55290158 |
| 87 | IKBKE | 0.54270374 |
| 88 | CHUK | 0.53489801 |
| 89 | TGFBR1 | 0.53098660 |
| 90 | KIT | 0.51755624 |
| 91 | MTOR | 0.51204296 |
| 92 | JAK2 | 0.50100174 |
| 93 | EPHB2 | 0.47599840 |
| 94 | PRKAA1 | 0.47514501 |
| 95 | SIK1 | 0.47514053 |
| 96 | PRPF4B | 0.46308845 |
| 97 | MAP2K3 | 0.46274084 |
| 98 | MAP3K2 | 0.45554085 |
| 99 | MAP3K1 | 0.44872930 |
| 100 | MAP2K1 | 0.44843941 |
| 101 | MAPK7 | 0.43334267 |
| 102 | PAK2 | 0.42163346 |
| 103 | IRAK2 | 0.41932893 |
| 104 | CDK9 | 0.41728893 |
| 105 | LATS1 | 0.41388094 |
| 106 | PRKD2 | 0.40103416 |
| 107 | PHKG2 | 0.39937657 |
| 108 | PHKG1 | 0.39937657 |
| 109 | MAPKAPK3 | 0.39713074 |
| 110 | PRKCE | 0.39669583 |
| 111 | ICK | 0.39251620 |
| 112 | MAP3K13 | 0.38153592 |
| 113 | PLK2 | 0.37712554 |
| 114 | HCK | 0.36722511 |
| 115 | ROCK1 | 0.36717391 |
| 116 | BCR | 0.35884674 |
| 117 | PAK4 | 0.35233699 |
| 118 | IGF1R | 0.35155453 |
| 119 | INSR | 0.35119182 |
| 120 | PTK2B | 0.34818627 |
| 121 | FGFR1 | 0.34514240 |
| 122 | MAPK10 | 0.34473543 |
| 123 | SGK1 | 0.34093634 |
| 124 | MAPK3 | 0.33939519 |
| 125 | TIE1 | 0.31888340 |
| 126 | CSK | 0.31565040 |
| 127 | NUAK1 | 0.31505080 |
| 128 | PRKG1 | 0.31475095 |
| 129 | PDPK1 | 0.31447505 |
| 130 | PKN1 | 0.31428111 |
| 131 | MAPK12 | 0.30323218 |
| 132 | ZAK | 0.30285661 |
| 133 | MAP3K12 | 0.30127793 |
| 134 | ABL1 | 0.29530771 |
| 135 | MAPK1 | 0.28841651 |
| 136 | NEK6 | 0.28777561 |
| 137 | BRD4 | 0.27603535 |
| 138 | BMPR2 | 0.26774435 |
| 139 | PDGFRB | 0.26433317 |
| 140 | PRKD1 | 0.26288700 |
| 141 | ZAP70 | 0.26006775 |
| 142 | MAPK14 | 0.25657024 |
| 143 | CDK6 | 0.25634731 |
| 144 | BMPR1B | 0.25345992 |
| 145 | NME2 | 0.25070678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.72159282 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 3.00795554 |
| 3 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.90987691 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.72725593 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.57197811 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.41926710 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.39988286 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36592422 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.33142674 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.18112763 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.15433690 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.08689254 |
| 13 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.08360937 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.88740286 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.87186741 |
| 16 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.84146033 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.75244230 |
| 18 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.71440115 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.51269095 |
| 20 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.42528890 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.42525669 |
| 22 | Mineral absorption_Homo sapiens_hsa04978 | 1.39579291 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31297377 |
| 24 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.28696414 |
| 25 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.27769432 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.26667252 |
| 27 | Focal adhesion_Homo sapiens_hsa04510 | 1.25759237 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.23195692 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.20051916 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18663844 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.17189113 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.13439584 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12306371 |
| 34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11357097 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.09881979 |
| 36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08964990 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05208340 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.03919465 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03451278 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99211535 |
| 41 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.98133207 |
| 42 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98046280 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96668080 |
| 44 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96440019 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 0.95151420 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94141919 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91817176 |
| 48 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90164575 |
| 49 | Prostate cancer_Homo sapiens_hsa05215 | 0.89858713 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89477086 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88477155 |
| 52 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87859746 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.86860079 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 0.84436902 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84275720 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83972626 |
| 57 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.81816319 |
| 58 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.81578825 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81483768 |
| 60 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76641913 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74419796 |
| 62 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74077123 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.73382649 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73361751 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73114963 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72343947 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71718796 |
| 68 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.71565925 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71293429 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71063876 |
| 71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70275609 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70167095 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70107141 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69231772 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68406538 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.66996763 |
| 77 | Insulin secretion_Homo sapiens_hsa04911 | 0.66778391 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66376623 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.66182143 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.66057692 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65849015 |
| 82 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65675878 |
| 83 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64062273 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63127539 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63023567 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61034164 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60335693 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59689882 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59290248 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.58922966 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58619592 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58098083 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57779086 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57493538 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57256373 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57076734 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.56866097 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56703289 |
| 99 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55376417 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.54745026 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54518656 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.54492737 |
| 103 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54119730 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52589300 |
| 105 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50727472 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50407327 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50216519 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49699020 |
| 109 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.48869283 |
| 110 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48774075 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48736470 |
| 112 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47603309 |
| 113 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47332744 |
| 114 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47322196 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47213690 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47135790 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45902216 |
| 118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45590891 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45189418 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44859425 |
| 121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44037232 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43907784 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43897572 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.43649104 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41518535 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41026859 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40936756 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40458370 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40321299 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37976447 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.37729802 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37712450 |
| 133 | Melanogenesis_Homo sapiens_hsa04916 | 0.37610956 |
| 134 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.37124918 |
| 135 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.35912534 |
| 136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35598565 |
| 137 | Axon guidance_Homo sapiens_hsa04360 | 0.35441729 |
| 138 | Lysine degradation_Homo sapiens_hsa00310 | 0.34976073 |
| 139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34858168 |
| 140 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34819912 |
| 141 | Adherens junction_Homo sapiens_hsa04520 | 0.34388422 |
| 142 | ABC transporters_Homo sapiens_hsa02010 | 0.32814870 |
| 143 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32410965 |
| 144 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31862393 |
| 145 | Bile secretion_Homo sapiens_hsa04976 | 0.30344303 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.29790844 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29407432 |
| 148 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29213712 |
| 149 | Gap junction_Homo sapiens_hsa04540 | 0.28580767 |
| 150 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28481384 |
| 151 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27408234 |
| 152 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27209109 |
| 153 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27071616 |

